Approximately every 40 seconds, an American will have a heart attack. Accurate and immediate biomarker testing at the emergency room is an imperative component of the initial diagnosis of patients. Implementation of Point-of-Care testing (POCT) for heart attack biomarkers have shown to improve patient outcome and operational efficiency. RAPIDKardia Diagnostic, Inc. will enter the POCT industry by introducing a device capable of detecting a specific biomarker to diagnose a heart attack. This proposal will outline what is required to begin RAPIDKardia Diagnostic, Inc. and maintain the business through profitability.
|Commitee:||Gerard, Nathan, Sinay, Tony|
|School:||California State University, Long Beach|
|Department:||Health Care Administration|
|School Location:||United States -- California|
|Source:||MAI 81/3(E), Masters Abstracts International|
|Subjects:||Health care management|
|Keywords:||Acute myocardial infarction, AMI, Cardiac testing, Heart attack, Point of care testing, Troponin|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be